Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1)
申请人:Merck Sharp & Dohme Ltd.
公开号:US07449585B2
公开(公告)日:2008-11-11
Compounds of formula (I), which are useful as therapeutic compounds, particularly in the treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1).
公式(I)的化合物,可用作治疗化合物,特别用于治疗通过调节vanilloid-1受体(VR1)的功能改善的疼痛和其他病症。